Nara Lokesh helped facilitate a ₹16-crore Zolgensma gene therapy for a baby with SMA Type-1 in Kurnool, bridging funding gaps and coordinating approvals, enabling timely life-saving treatment with support from public donations and medical teams
The work of the CGT facility will span across multiple things - from boosting immune responses against cancer to ensuring that therapeutic proteins are safely accepted in patients with genetic diseases like haemophilia
Launching the gene therapy treatment called “CAR-T cell therapy” at IIT Bombay, President Murmu said that it will be successful in giving new lives to countless patients.
The findings, published in the journal Science Translational Medicine, suggested that replacing one faulty gene that codes for a protein known as podocin could cure the condition.
Hyderabad: This concept may seem quite fictional and even futuristic. However, this is what geneticists worldwide through gene therapy are pursuing, while trying to find cure for a wide range of diseases that challenge modern medicine including cancers, heart diseases, diabetes, haemophilia, AIDS, genetic disorders, among others. Gene therapy involves altering the genes inside the […]
Hyderabad: A 23-month-old baby with Spinal Muscular Atrophy (SMA) Type 1, received a new lease of life with Swiss drugmaker Novartis coming forward to donate gene therapy costing Rs 16 crore. Baby Ellen was administered Zolgensma gene therapy, called the world’s costliest drug, at a private hospital in Hyderabad on August 6, her father Rayapudi […]
Hyderabad: A team of researchers from University of California, San Diego, in a study on mice have demonstrated that gene therapy can reduce pain resulting from spinal cord injuries or other nerve injuries, without side effects. The study on mice by University of California researchers, which was published online in Molecular Therapy on May 5, […]
